About Valiant Laboratories Limited
Data last updated: 05 January 2026
Valiant Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 16 August 2021, the company has been in operation for over 5 years.
Registered with ROC Mumbai under CIN L24299MH2021PLC365904. Listed.
Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹54.31 Cr. It is led by directors including Velji Karamshi Gogri and Paresh Shashikant Shah.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: 104 Udyog Kshetra Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, India – 400080.
As per the financials filed for FY 2023, the company reported a revenue of ₹338.77 Cr, a growth of 61% compared to the previous year.
The company has a workforce of approximately 77 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Valiant Laboratories. As per MCA filings, the company has open charges of ₹62.4 Cr and satisfied charges of ₹52 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website valiantlabs.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address104 Udyog Kshetra Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, India – 400080
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Valiant Laboratories Limited
Valiant Laboratories Limited has one previous CIN (Corporate Identification Number): U24299MH2021PLC365904. The current CIN is L24299MH2021PLC365904, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24299MH2021PLC365904 | Current |
| U24299MH2021PLC365904 | Previous |
Associated Brands with Valiant Laboratories Limited
Valiant Laboratories Limited operates one associated brand: Valiant Laboratories. These brands represent Valiant Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Valiant Laboratories is engaged in manufacturing active pharmaceutical ingredients. | valiantlabs.in |
Business Activity of Valiant Laboratories Limited
Valiant Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Valiant Laboratories Limited
Valiant Laboratories Limited is audited by Raman S. Shah & Co. (ICAI peer reviewed, certificate valid till 2029-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Raman S. Shah & Co. (ICAI peer reviewed, certificate valid till 2029-02-28) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Valiant Laboratories Limited
Valiant Laboratories Limited is currently managed by 10 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Velji Karamshi Gogri | Director | 06 Feb 2022 | 4 Years 5 Months | Current |
| Paresh Shashikant Shah | Whole-Time Director | 16 Aug 2021 | 4 Years 10 Months | Current |
| Shantilal Shivji Vora | Director | 16 Aug 2021 | 4 Years 10 Months | Current |
|
Sandeep Gupta
Also directs:
Alchemie Finechem Private Limited
|
Director | 23 Feb 2023 | 3 Years 4 Months | Current |
| Sonal Amit Vira | Director | 16 Feb 2022 | 4 Years 4 Months | Current |
|
Ashok Lakhamshi Chheda
Also directs:
Stature Realtor Private Limited
|
Director | 12 Nov 2024 | 1 Years 7 Months | Current |
Financials of Valiant Laboratories Limited FY 2026 filings available
Valiant Laboratories Limited reported revenue of ₹237.47 Cr (up 78.04% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue from Operations | ₹237.47 Cr | ₹133.38 Cr | ₹182.06 Cr |
| Other Income | ₹2.32 Cr | ₹5.43 Cr | ₹9.68 Cr |
| Total Income | ₹239.79 Cr | ₹138.82 Cr | ₹191.74 Cr |
| Cost of Materials Consumed | ₹190.8 Cr | ₹112.18 Cr | ₹169.39 Cr |
| Purchases of Stock-in-Trade | ₹9.05 Cr | ₹56.14 Lakh | -₹45.09 Lakh |
| Changes in Inventories | -₹2.68 Cr | ₹3.86 Cr | -₹68.54 Lakh |
| Employee Benefit Expense | ₹7 Cr | ₹4.39 Cr | ₹4.31 Cr |
| Finance Costs | ₹1.9 Cr | ₹17.53 Lakh | ₹7.78 Lakh |
| Depreciation & Amortisation | ₹6.04 Cr | ₹2.09 Cr | ₹1.97 Cr |
| Other Expenses | ₹26.92 Cr | ₹17.07 Cr | ₹17.9 Cr |
| Total Expenses | ₹239.02 Cr | ₹140.33 Cr | ₹192.51 Cr |
| Profit Before Exceptional Items & Tax | ₹76.82 Lakh | -₹1.51 Cr | -₹76.95 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹76.82 Lakh | -₹1.51 Cr | -₹76.95 Lakh |
| Total Tax Expense | ₹4.04 Cr | ₹68.86 Lakh | -₹1.09 Cr |
| Net Profit | -₹3.27 Cr | -₹2.2 Cr | ₹31.96 Lakh |
| attributable to Owners | -₹3.27 Cr | -₹2.2 Cr | ₹31.96 Lakh |
| attributable to NCI | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹42,000 | -₹2.4 Lakh | ₹17.54 Lakh |
| Total Comprehensive Income | -₹3.26 Cr | -₹2.23 Cr | ₹49.5 Lakh |
| EBITDA (computed) | ₹8.71 Cr | ₹75.53 Lakh | ₹1.27 Cr |
| Basic EPS | ₹-0.51 | ₹-0.51 | ₹0.13 |
| Diluted EPS | ₹-0.51 | ₹-0.51 | ₹0.13 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Assets | ₹463.98 Cr | ₹400.86 Cr | ₹342.69 Cr |
| Non-current Assets | ₹235.65 Cr | ₹208.24 Cr | ₹117.14 Cr |
| Current Assets | ₹228.32 Cr | ₹192.62 Cr | ₹225.54 Cr |
| Property, Plant & Equipment | ₹227.01 Cr | ₹48.33 Cr | ₹50.05 Cr |
| Inventories | ₹45.43 Cr | ₹3.99 Cr | ₹10.02 Cr |
| Trade Receivables | ₹93.56 Cr | ₹72.12 Cr | ₹45.73 Cr |
| Cash & Equivalents | ₹3.53 Cr | ₹4.92 Cr | ₹11.72 Cr |
| Equity (Net Worth) | ₹310.89 Cr | ₹234.31 Cr | ₹236.86 Cr |
| Equity Share Capital | ₹54.31 Cr | ₹43.45 Cr | ₹43.45 Cr |
| Borrowings (Non-current) | ₹28.09 Cr | ₹104.35 Cr | ₹74.66 Cr |
| Borrowings (Current) | ₹16.86 Cr | ₹16.86 Cr | ₹1.39 Cr |
| Total Debt (computed) | ₹44.95 Cr | ₹121.2 Cr | ₹76.05 Cr |
| Current Liabilities | ₹119.45 Cr | ₹59.62 Cr | ₹29.08 Cr |
| Total Liabilities | ₹153.09 Cr | ₹166.55 Cr | ₹105.83 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating Cash Flow | -₹10.43 Cr | ₹1.31 Cr | ₹1.89 Cr |
| Investing Cash Flow | ₹7.25 Cr | -₹52.77 Cr | -₹143.88 Cr |
| Financing Cash Flow | ₹1.79 Cr | ₹44.65 Cr | ₹152.45 Cr |
| Capital Expenditure | ₹34.2 Cr | ₹113.85 Cr | ₹45.87 Cr |
| Free Cash Flow (computed) | -₹44.63 Cr | -₹112.54 Cr | -₹43.98 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.39 Cr | -₹6.8 Cr | ₹10.46 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹91.98 Cr | ₹52.46 Cr | ₹46.2 Cr | ₹46.82 Cr | ₹57.79 Cr | ₹35.23 Cr | ₹21.48 Cr | ₹18.88 Cr | ₹30.59 Cr | ₹40.52 Cr | ₹59.55 Cr |
| Other Income | ₹17.12 Lakh | ₹62.78 Lakh | ₹86.6 Lakh | ₹65.54 Lakh | -₹2.31 Cr | ₹1.58 Cr | ₹3.36 Cr | ₹2.81 Cr | ₹2.5 Cr | ₹1.78 Cr | ₹2.96 Cr |
| Total Income | ₹92.15 Cr | ₹53.09 Cr | ₹47.07 Cr | ₹47.48 Cr | ₹55.47 Cr | ₹36.81 Cr | ₹24.84 Cr | ₹21.7 Cr | ₹33.09 Cr | ₹42.29 Cr | ₹62.51 Cr |
| Cost of Materials Consumed | ₹68.46 Cr | ₹44.5 Cr | ₹42.37 Cr | ₹35.46 Cr | ₹46.78 Cr | ₹29.28 Cr | ₹16.68 Cr | ₹19.68 Cr | ₹30.69 Cr | ₹37.85 Cr | ₹55.39 Cr |
| Purchases of Stock-in-Trade | ₹2.48 Cr | ₹1.87 Cr | ₹14,000 | ₹4.7 Cr | ₹27.88 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹1.2 Cr | -₹1.4 Cr | -₹2.04 Cr | -₹44.09 Lakh | ₹1.16 Cr | -₹55.63 Lakh | ₹3.92 Cr | -₹67.5 Lakh | -₹68.54 Lakh | ₹3.28 Cr | -₹57.23 Lakh |
| Employee Benefit Expense | ₹2.56 Cr | ₹1.95 Cr | ₹1.29 Cr | ₹1.2 Cr | ₹1.13 Cr | ₹1.11 Cr | ₹1.19 Cr | ₹95.95 Lakh | ₹1.26 Cr | ₹1.21 Cr | ₹1.04 Cr |
| Finance Costs | ₹1.01 Cr | ₹68.21 Lakh | ₹13.59 Lakh | ₹7.33 Lakh | ₹5.45 Lakh | ₹6.19 Lakh | ₹61,000 | ₹5.29 Lakh | ₹2.07 Lakh | ₹1.87 Lakh | ₹1.91 Lakh |
| Depreciation & Amortisation | ₹2.93 Cr | ₹2.05 Cr | ₹53.22 Lakh | ₹53.26 Lakh | ₹51.77 Lakh | ₹52.17 Lakh | ₹51.87 Lakh | ₹53.46 Lakh | ₹51.94 Lakh | ₹49.45 Lakh | ₹49 Lakh |
| Other Expenses | ₹12.47 Cr | ₹6.43 Cr | ₹4.51 Cr | ₹3.51 Cr | ₹4.61 Cr | ₹4.78 Cr | ₹6.44 Cr | ₹1.31 Cr | ₹3.85 Cr | ₹4.48 Cr | ₹5.08 Cr |
| Total Expenses | ₹91.11 Cr | ₹56.08 Cr | ₹46.79 Cr | ₹45.03 Cr | ₹54.53 Cr | ₹35.19 Cr | ₹28.74 Cr | ₹21.86 Cr | ₹35.66 Cr | ₹47.33 Cr | ₹61.44 Cr |
| Profit Before Exceptional Items & Tax | ₹1.05 Cr | -₹2.99 Cr | ₹27.65 Lakh | ₹2.45 Cr | ₹93.91 Lakh | ₹1.62 Cr | -₹3.91 Cr | -₹16.2 Lakh | -₹2.57 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.05 Cr | -₹2.99 Cr | ₹27.65 Lakh | ₹2.45 Cr | ₹93.91 Lakh | ₹1.62 Cr | -₹3.91 Cr | -₹16.2 Lakh | -₹2.57 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Total Tax Expense | -₹71.19 Lakh | ₹4.07 Cr | ₹7.64 Lakh | ₹62.78 Lakh | ₹23.55 Lakh | -₹72.67 Lakh | ₹83.25 Lakh | ₹34.74 Lakh | -₹1.33 Cr | -₹1.54 Cr | ₹27.05 Lakh |
| Net Profit | ₹1.76 Cr | -₹7.06 Cr | ₹20.01 Lakh | ₹1.82 Cr | ₹70.36 Lakh | ₹2.35 Cr | -₹4.74 Cr | -₹50.94 Lakh | -₹1.24 Cr | -₹3.5 Cr | ₹79.34 Lakh |
| attributable to Owners | ₹1.76 Cr | -₹7.06 Cr | ₹20.01 Lakh | - | ₹70.36 Lakh | ₹2.35 Cr | -₹4.74 Cr | - | -₹1.24 Cr | -₹3.5 Cr | ₹79.34 Lakh |
| attributable to NCI | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹20,000 | ₹0 | ₹22,000 | ₹0 | -₹2.4 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹17.54 Lakh |
| Total Comprehensive Income | ₹1.76 Cr | -₹7.06 Cr | ₹20.23 Lakh | ₹1.82 Cr | ₹67.96 Lakh | ₹2.35 Cr | -₹4.74 Cr | -₹50.94 Lakh | -₹1.24 Cr | -₹3.5 Cr | ₹96.88 Lakh |
| EBITDA (computed) | ₹4.98 Cr | -₹26.01 Lakh | ₹94.46 Lakh | ₹3.05 Cr | ₹1.51 Cr | ₹2.2 Cr | -₹3.38 Cr | ₹42.55 Lakh | -₹2.03 Cr | -₹4.53 Cr | ₹1.57 Cr |
| Basic EPS | ₹0.32 | ₹-1.30 | ₹0.04 | ₹0.42 | ₹0.16 | ₹0.54 | ₹-1.09 | ₹-0.12 | ₹-0.33 | ₹-0.81 | ₹0.24 |
| Diluted EPS | ₹0.35 | ₹-1.44 | ₹0.04 | ₹0.42 | ₹0.16 | ₹0.54 | ₹-1.09 | ₹-0.12 | ₹-0.33 | ₹-0.81 | ₹0.24 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue from Operations | ₹217.04 Cr | ₹133.36 Cr | ₹182.05 Cr |
| Other Income | ₹2.89 Cr | ₹5.43 Cr | ₹9.68 Cr |
| Total Income | ₹219.94 Cr | ₹138.79 Cr | ₹191.73 Cr |
| Cost of Materials Consumed | ₹171.53 Cr | ₹112.16 Cr | ₹169.39 Cr |
| Purchases of Stock-in-Trade | ₹15.57 Cr | ₹56.14 Lakh | ₹0 |
| Changes in Inventories | ₹21.38 Lakh | ₹3.86 Cr | -₹1.14 Cr |
| Employee Benefit Expense | ₹5 Cr | ₹4.39 Cr | ₹4.31 Cr |
| Finance Costs | ₹26.11 Lakh | ₹17.53 Lakh | ₹7.78 Lakh |
| Depreciation & Amortisation | ₹2.26 Cr | ₹2.02 Cr | ₹1.95 Cr |
| Other Expenses | ₹17.56 Cr | ₹17.07 Cr | ₹17.9 Cr |
| Total Expenses | ₹212.39 Cr | ₹140.24 Cr | ₹192.49 Cr |
| Profit Before Exceptional Items & Tax | ₹7.55 Cr | -₹1.45 Cr | -₹75.25 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹7.55 Cr | -₹1.45 Cr | -₹75.25 Lakh |
| Total Tax Expense | ₹2 Cr | ₹70.24 Lakh | -₹1.09 Cr |
| Net Profit | ₹5.55 Cr | -₹2.15 Cr | ₹34.03 Lakh |
| Other Comprehensive Income | -₹43,000 | -₹2.26 Lakh | ₹17.54 Lakh |
| Total Comprehensive Income | ₹5.54 Cr | -₹2.17 Cr | ₹51.57 Lakh |
| EBITDA (computed) | ₹10.07 Cr | ₹75.21 Lakh | ₹1.27 Cr |
| Basic EPS | ₹1.02 | ₹-0.50 | ₹0.14 |
| Diluted EPS | ₹1.10 | ₹-0.50 | ₹0.14 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Assets | ₹385.89 Cr | ₹317.28 Cr | ₹324.73 Cr |
| Non-current Assets | ₹196.57 Cr | ₹198.06 Cr | ₹115.46 Cr |
| Current Assets | ₹189.32 Cr | ₹119.22 Cr | ₹209.27 Cr |
| Property, Plant & Equipment | ₹29.59 Cr | ₹29.94 Cr | ₹31.61 Cr |
| Inventories | ₹22.97 Cr | ₹3.96 Cr | ₹10.02 Cr |
| Trade Receivables | ₹83.25 Cr | ₹72.1 Cr | ₹45.72 Cr |
| Cash & Equivalents | ₹3.07 Cr | ₹4.8 Cr | ₹2.23 Cr |
| Equity (Net Worth) | ₹319.76 Cr | ₹234.38 Cr | ₹236.88 Cr |
| Equity Share Capital | ₹54.31 Cr | ₹43.45 Cr | ₹43.45 Cr |
| Borrowings (Non-current) | ₹0 | ₹59.4 Cr | ₹59.4 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹59.4 Cr | ₹59.4 Cr |
| Current Liabilities | ₹62.68 Cr | ₹20.95 Cr | ₹26.36 Cr |
| Total Liabilities | ₹66.13 Cr | ₹82.9 Cr | ₹87.85 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating Cash Flow | -₹13.81 Cr | -₹21.9 Cr | ₹48.78 Cr |
| Investing Cash Flow | -₹8.09 Cr | ₹24.97 Cr | -₹182.73 Cr |
| Financing Cash Flow | ₹20.17 Cr | -₹50.13 Lakh | ₹135.8 Cr |
| Capital Expenditure | ₹1.16 Cr | ₹56.14 Lakh | ₹3.76 Cr |
| Free Cash Flow (computed) | -₹14.97 Cr | -₹22.46 Cr | ₹45.02 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.73 Cr | ₹2.57 Cr | ₹1.85 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹65.3 Cr | ₹54.74 Cr | ₹45.99 Cr | ₹51.01 Cr | ₹57.77 Cr | ₹35.23 Cr | ₹21.48 Cr | ₹18.88 Cr | ₹30.58 Cr | ₹40.52 Cr | ₹59.55 Cr |
| Other Income | ₹77.27 Lakh | ₹60.51 Lakh | ₹84.57 Lakh | ₹67.13 Lakh | ₹65.39 Lakh | ₹66.62 Lakh | ₹1.93 Cr | ₹2.17 Cr | ₹2.5 Cr | ₹1.78 Cr | ₹2.96 Cr |
| Total Income | ₹66.08 Cr | ₹55.35 Cr | ₹46.83 Cr | ₹51.68 Cr | ₹58.42 Cr | ₹35.89 Cr | ₹23.41 Cr | ₹21.06 Cr | ₹33.09 Cr | ₹42.29 Cr | ₹62.51 Cr |
| Cost of Materials Consumed | ₹49.5 Cr | ₹40.15 Cr | ₹42.18 Cr | ₹39.69 Cr | ₹46.77 Cr | ₹29.26 Cr | ₹16.68 Cr | ₹19.68 Cr | ₹30.68 Cr | ₹37.85 Cr | ₹55.39 Cr |
| Purchases of Stock-in-Trade | ₹2.48 Cr | ₹8.39 Cr | ₹14,000 | ₹4.7 Cr | ₹27.88 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹2.19 Cr | ₹50.56 Lakh | -₹2.04 Cr | -₹44.09 Lakh | ₹1.16 Cr | -₹54.29 Lakh | ₹3.92 Cr | -₹67.5 Lakh | -₹68.54 Lakh | ₹3.28 Cr | -₹57.24 Lakh |
| Employee Benefit Expense | ₹1.29 Cr | ₹1.24 Cr | ₹1.28 Cr | ₹1.19 Cr | ₹1.13 Cr | ₹1.11 Cr | ₹1.19 Cr | ₹95.95 Lakh | ₹1.26 Cr | ₹1.21 Cr | ₹1.04 Cr |
| Finance Costs | ₹1.72 Lakh | ₹3.47 Lakh | ₹13.59 Lakh | ₹7.33 Lakh | ₹5.45 Lakh | ₹6.19 Lakh | ₹61,000 | ₹5.29 Lakh | ₹2.07 Lakh | ₹1.87 Lakh | ₹1.91 Lakh |
| Depreciation & Amortisation | ₹52.12 Lakh | ₹71.53 Lakh | ₹51.14 Lakh | ₹51.41 Lakh | ₹50.53 Lakh | ₹50.9 Lakh | ₹50.6 Lakh | ₹50.44 Lakh | ₹50.17 Lakh | ₹49.45 Lakh | ₹49 Lakh |
| Other Expenses | ₹5.34 Cr | ₹4.21 Cr | ₹4.5 Cr | ₹3.5 Cr | ₹4.6 Cr | ₹4.78 Cr | ₹6.44 Cr | ₹1.31 Cr | ₹3.85 Cr | ₹4.48 Cr | ₹5.08 Cr |
| Total Expenses | ₹61.34 Cr | ₹55.24 Cr | ₹46.58 Cr | ₹49.23 Cr | ₹54.5 Cr | ₹35.18 Cr | ₹28.73 Cr | ₹21.83 Cr | ₹35.64 Cr | ₹47.33 Cr | ₹61.44 Cr |
| Profit Before Exceptional Items & Tax | ₹4.73 Cr | ₹10.93 Lakh | ₹25.79 Lakh | ₹2.45 Cr | ₹3.92 Cr | ₹71.91 Lakh | -₹5.32 Cr | -₹77.19 Lakh | -₹2.55 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹4.73 Cr | ₹10.93 Lakh | ₹25.79 Lakh | ₹2.45 Cr | ₹3.92 Cr | ₹71.91 Lakh | -₹5.32 Cr | -₹77.19 Lakh | -₹2.55 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Total Tax Expense | ₹1.2 Cr | ₹7.63 Lakh | ₹9.12 Lakh | ₹63.01 Lakh | ₹68.53 Lakh | -₹88.1 Lakh | ₹66.43 Lakh | ₹23.38 Lakh | -₹1.33 Cr | -₹1.54 Cr | ₹27.05 Lakh |
| Net Profit | ₹3.53 Cr | ₹3.3 Lakh | ₹16.67 Lakh | ₹1.82 Cr | ₹3.24 Cr | ₹1.6 Cr | -₹5.98 Cr | -₹1.01 Cr | -₹1.22 Cr | -₹3.5 Cr | ₹79.34 Lakh |
| Other Comprehensive Income | -₹1.25 Lakh | ₹0 | ₹82,000 | ₹0 | -₹2.27 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹17.54 Lakh |
| Total Comprehensive Income | ₹3.52 Cr | ₹3.3 Lakh | ₹17.49 Lakh | ₹1.82 Cr | ₹3.22 Cr | ₹1.6 Cr | -₹5.98 Cr | -₹1.01 Cr | -₹1.22 Cr | -₹3.5 Cr | ₹96.88 Lakh |
| EBITDA (computed) | ₹5.27 Cr | ₹85.93 Lakh | ₹90.52 Lakh | ₹3.03 Cr | ₹4.48 Cr | ₹1.29 Cr | -₹4.81 Cr | -₹21.46 Lakh | -₹2.03 Cr | -₹4.53 Cr | ₹1.57 Cr |
| Basic EPS | ₹0.65 | ₹0.01 | ₹0.03 | ₹0.42 | ₹0.74 | ₹0.37 | ₹-1.39 | ₹-0.23 | ₹-0.32 | ₹-0.81 | ₹0.24 |
| Diluted EPS | ₹0.70 | ₹0.01 | ₹0.03 | ₹0.42 | ₹0.74 | ₹0.37 | ₹-1.39 | ₹-0.23 | ₹-0.32 | ₹-0.81 | ₹0.24 |
Shareholding Pattern of Valiant Laboratories Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 74.94%, foreign institutional investors hold 0.20%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 24.86% of Valiant Laboratories Limited. The company had 14,657 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Aug 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| Public | 25.06% | 25.06% | 25.06% | 25.06% | 25.06% | 25.06% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% |
| Public | 25.06% | 25.06% | 25.06% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Board & Governance of Valiant Laboratories Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Valiant Laboratories Limited has 7 directors - 3 independent and 2 executive. The board is chaired by Mulesh Manilal Savla.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Mulesh Manilal Savla | Non-Executive - Independent Director · Chairperson | 2024-05-14 | 2 |
| Paresh Shashikant Shah | Executive Director | 2021-08-16 | 1 |
| Santosh Shantilal Vora | Executive Director · MD | 2021-08-16 | 2 |
| Shantilal Shivji Vora | Non-Executive - Non Independent Director | 2021-08-16 | 1 |
| Sonal Amit Vira | Non-Executive - Independent Director | 2022-02-16 | 2 |
| Sandeep Gupta | Non-Executive - Non Independent Director | 2023-02-23 | 1 |
| Ashok Lakhamshi Chheda | Non-Executive - Independent Director | 2024-11-12 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Mulesh Manilal Savla (Chairperson), Sonal Amit Vira, Shantilal Shivji Vora, Ashok Lakhamshi Chheda |
| Nomination and remuneration committee | Sonal Amit Vira (Chairperson), Shantilal Shivji Vora, Mulesh Manilal Savla |
| Stakeholders Relationship Committee | Mulesh Manilal Savla (Chairperson), Sonal Amit Vira, Santosh Shantilal Vora |
| Risk Management Committee | Santosh Shantilal Vora (Chairperson), Sonal Amit Vira, Mulesh Manilal Savla, Paresh Shashikant Shah |
| Corporate Social Responsibility Committee | Mulesh Manilal Savla (Chairperson), Paresh Shashikant Shah, Shantilal Shivji Vora |
| Restructuring Committee | Mulesh Manilal Savla (Chairperson), Ashok Lakhamshi Chheda, Santosh Shantilal Vora |
Group Structure of Valiant Laboratories Limited
Valiant Laboratories Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Valiant Laboratories Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Valiant Advanced Sciences Private Limited | U24290MH2022PTC386388 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Valiant Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2025 | The Hongkong and Shanghai Banking Corporation Limited | ₹1 Cr | Open |
| 08 Jun 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹4.4 Cr | Open |
| 28 Feb 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹5 Cr | Open |
| 23 Sep 2022 | Others | ₹52 Cr | Open |
| 14 Oct 2022 | Others | ₹52 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Valiant Laboratories Limited
Valiant Laboratories Limited has a workforce of 77 employees as of Apr 08, 2025.
Employee Count & EPFO Data of Valiant Laboratories Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Valiant Laboratories Limited
GSTIN & GST Filing Data of Valiant Laboratories Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Valiant Laboratories Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Valiant Laboratories Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Valiant Laboratories Limited
MSME Payment Delays by Valiant Laboratories Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Valiant Laboratories Limited
Subsidiaries & Group Companies of Valiant Laboratories Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Valiant Laboratories Limited with ownership details.
MCA Filings & Documents of Valiant Laboratories Limited
MCA Filings & Documents of Valiant Laboratories Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Valiant Laboratories Limited
Recent News on Valiant Laboratories Limited
Frequently Asked Questions about Valiant Laboratories Limited
Valiant Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 16 August 2021 (5+ years old) and is registered under CIN L24299MH2021PLC365904. The company has 77 employees.
Valiant Laboratories Limited reported revenue of ₹338.77 Cr for FY 2023 (up 61.00% YoY).
The current directors of Valiant Laboratories Limited are:
- Velji Karamshi Gogri
- Paresh Shashikant Shah
- Shantilal Shivji Vora
- Prajakta Kantishwar Patil
- Sandeep Gupta
- Sonal Amit Vira
- Ashok Lakhamshi Chheda
- Santosh Shantilal Vora
- Mulesh Manilal Savla
- Akshay Dnyaneshwar Gangurde
The primary industry of Valiant Laboratories Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes, Valiant Laboratories Limited is a listed company.
Valiant Laboratories Limited can be reached at the registered office: 104 Udyog Kshetra Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, India – 400080, or through the website valiantlabs.in.